Trials / Conditions / Reflux Esophagitis (RE)
Reflux Esophagitis (RE)
4 registered clinical trials studyying Reflux Esophagitis (RE) — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Clinical Trial of Anaprazole for Treating Reflux Esophagitis. NCT07010107 | Xuanzhu Biopharmaceutical Co., Ltd. | Phase 3 |
| Recruiting | A Phase III Clinical Trial for Efficacy and Safety Evaluation of JP-1366 Tablets on Reflux Esophagitis NCT06850480 | Livzon Pharmaceutical Group Inc. | Phase 3 |
| Completed | A Phase I/III Study of D961H 10 mg and 20 mg in Japanese Paediatric Patients With Gastrointestinal Acid Relate NCT02153398 | AstraZeneca | Phase 3 |
| Completed | Analysis of GERD Symptoms Using Gastroesophageal Reflux Impact Score Questionnaire for Quality of Life NCT01536080 | Seoul National University Bundang Hospital | — |